A detailed history of Philadelphia Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Philadelphia Trust CO holds 525,518 shares of VTRS stock, worth $6.58 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
525,518
Previous 506,559 3.74%
Holding current value
$6.58 Million
Previous $5.39 Million 13.3%
% of portfolio
0.44%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $195,656 - $229,972
18,959 Added 3.74%
525,518 $6.1 Million
Q2 2024

Aug 13, 2024

BUY
$10.05 - $12.02 $969,181 - $1.16 Million
96,436 Added 23.51%
506,559 $5.39 Million
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $2.63 Million - $3.15 Million
233,141 Added 131.73%
410,123 $4.9 Million
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $1.01 Million - $1.25 Million
115,000 Added 185.54%
176,982 $1.92 Million
Q3 2023

Nov 09, 2023

BUY
$9.59 - $11.35 $594,407 - $703,495
61,982 New
61,982 $611,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.